Infectious plasmodium sporozoites grown in vitro
US12171822B2 · kind B2 · utility
0Cited by
17References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2023 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Dec 7, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.